Part 1 Part 1 Part 1 Part 1 Part 1 Part 1 Part 2 Part 2 Part 2
LSF 5 mg ASD tablet 5 mg ASD tablet 5 mg ASD tablet 5 mg ASD tablet 5 mg ASD tablet 10 mg ASD tablet 10 mg ASD tablet 10 mg
System Organ Class Fasting N=11 n (%) GR fasting N=11 n (%)a GS fasting N=10 n (%) GR fed N=12 n (%) GS fed N=11 n (%) All subjects N=55 n (%) GR fasting N=12 n (%) GS fasting N=10 n (%) All subjects N=22 n (%)
Any TEAE 3 (27.3) 5 (45.5) 2 (20.0) 1 (8.3) 5 (45.5) 16 (29.1) 0 4 (40.0) 4 (18.2)
Nervous system disorders 1 (9.1) 2 (18.2) 1 (10.0) 1 (8.3) 3 (27.3) 8 (14.5) 0 2 (20.0) 2 (9.1)
Gastrointestinal disorders 1 (9.1) 1 (9.1) 1 (10.0) 0 1 (9.1) 4 (7.3) 0 1 (10.0) 1 (4.5)
Infections & infestations 0 1 (9.1) 1 (10.0) 0 1 (9.1) 3 (5.5) 0 0
Eye disorders 0 0 1 (10.0) 0 0 1 (1.8) 0 1 (10.0) 1 (4.5)
General disorders and administration site disorders 1 (9.1) 0 0 0 0 1 (1.8) 0 1 (10.0) 1 (4.5)
Skin and subcutaneous tissue disorders 0 1 (9.1) 0 0 0 1 (1.8) 0 0